Dyne Therapeutics, Inc. (DYN) News
Track canonical SquawkNews coverage tagged to DYN, Dyne Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 13 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
RBC Reiterates DYN Outperform
RBC raises DYN price target to $35
EQUITY | Jul 30, 2026, 11:13 AM UTC
L
DYN - Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
DYN - Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
EARNINGS | Jul 29, 2026, 08:30 PM UTC
L
Dyne Therapeutics receives FDA clearance to initiate DYNE-302 trial
Dyne Therapeutics...
REGULATION | Jul 28, 2026, 11:41 AM UTC
L
DYN new Overweight @ Cantor
DYN new Overweight @ Cantor
EQUITY | Jul 23, 2026, 12:08 PM UTC
L
DYN Initiated Overweight at Cantor Fitzgerald
DYN Initiated Overweight at Cantor Fitzgerald
EQUITY | Jul 23, 2026, 11:55 AM UTC
L
Today's priced deal • DYN 18.3M share Spot Secondary, priced at $20.50, by MSCO, JEFF, Evercore, LifeSci, RAJA & Jones
Today's priced deal • DYN 18.3M share Spot Secondary, priced at $20.50, by MSCO, JEFF, Evercore, LifeSci, RAJA & Jones
EQUITY | Jul 22, 2026, 12:59 PM UTC
L
DYN priced an upsized public stock offering, raising about $375M through the sale of 18.3M shares at $20.50 each, up from its initially prop
DYN priced an upsized public stock offering, raising about $375M through the sale of 18.3M shares at $20.50 each, up from its initially proposed $300M raise; shares -9.5% premarket
EQUITY | Jul 22, 2026, 10:30 AM UTC
H
Closing Bell Movers: Finward jumps after First Financial deal
Stock futures were sharply higher in after-hours, adding to the session's broad gains. Traders after the close saw early reporting mostly from smaller banks, though notable names included Capital One, Bank OZK, and Pegas
EARNINGS | Jul 21, 2026, 10:05 PM UTC
L
DYN -7% post mkt after offering headlines
DYN -7% post mkt after offering headlines
EQUITY | Jul 21, 2026, 08:48 PM UTC
L
DYN Dyne Therapeutics announces proposed public offering of common stock
DYN Dyne Therapeutics announces proposed public offering of common stock
EQUITY | Jul 21, 2026, 08:47 PM UTC
L
Dyne Therapeutics announces FDA acceptance of zeleciment rostudirsen BLA
Dyne Therapeutics...
REGULATION | Jul 20, 2026, 11:33 AM UTC
L
DYN Dyne Therapeutics announces U.S. FDA Acceptance of Biologics license application (bla) for z-rostudirsen in exon 51 duchenne muscular dy
DYN Dyne Therapeutics announces U.S. FDA Acceptance of Biologics license application (bla) for z-rostudirsen in exon 51 duchenne muscular dystrophy (dmd) Dyne Therapeutics, - FDA grants priority review with pdufa date Ja
REGULATION | Jul 20, 2026, 11:30 AM UTC
M
BDC: BUY @ Citi
Citi initiates BDC with a BUY rating, among other top initiations
EQUITY | Jun 26, 2026, 11:17 AM UTC